Multiple Myeloma Market Global Forecast Report by Drugs Types (Chemotherapy, Protease Inhibitors, Monoclonal Antibody, Others) Disease Types (Active multiple myeloma, Smoldering multiple myeloma) End User (Hospitals, Clinics, Others) Countries and Company

Multiple Myeloma Market Global Forecast Report by Drugs Types (Chemotherapy, Protease Inhibitors, Monoclonal Antibody, Others) Disease Types (Active multiple myeloma, Smoldering multiple myeloma) End User (Hospitals, Clinics, Others) Countries and Company Analysis, 2024-2032


Artificial Sweetener Market Analysis

Global Artificial Sweetener Market was US$ 6.64 Billion in 2023 and will grow US$ 10.30 Billion by 2032, with a CAGR of 5.00% from 2024 to 2032. The increased awareness of the health hazards connected with sugar consumption and consumers' changing dietary patterns are major factors driving the expansion of the artificial sweetener market. People are moving toward artificial sweeteners supplemented with vitamins, minerals, or other health-promoting substances as they grow more health-conscious.

Artificial Sweetener Market Overview

Artificial sweeteners, which are frequently found in processed foods and beverages like candies, jams, and baked goods, are frequently used as a sugar alternative to manage blood sugar levels. Among the most widely used artificial sweeteners on the market are saccharin, sodium benzoate, and aspartame; aspartame is a tabletop sweetener that is around 200 times sweeter than ordinary sugar. Cereal, coffee, sugar-free chewing gum, and low-calorie treats all contain it.

Due to the global surge in health-conscious customers, there has been a tremendous increase in demand for low- or no-calorie versions of food and beverages in recent years. Artificial sweeteners are used extensively in the food and beverage industry in items including soft drinks, sauces, chewing gum, jellies, dressings, baked goods, confectionery, fruit juice, ice cream, and more. They are sweeter than table sugar but have a lower energy density. The increased demand for low-sugar and diet beverages has led to a notable growth in the use of artificial sweeteners, especially in the soft drink sector.

Growth Factors in the Artificial Sweetener Industry

Rise in diabetes prevalence

Diabetes is a long-term, sometimes lethal condition for which there is no known cure. Over 400 million people worldwide suffer with diabetes, and treating the disease costs about 12% of all healthcare expenditures worldwide, according to the World Health Organization. Millions of people are affected by this global illness that has surfaced. Furthermore, the number of adults worldwide with diabetes was estimated to be 537 million in the IDF 2021 report, and that number is expected to rise to 643 million by 2030.

The demand for artificial sweeteners is anticipated to increase substantially owing to the increasing incidence of diabetes. Controlling blood sugar levels is more important than ever because type 2 diabetes cases, in particular, are on the rise worldwide. If you're trying to cut less on sugar but still want to enjoy sweet flavors, artificial sweeteners are a good option. These sugar alternatives are appealing to diabetics and those at risk because they offer a means of satisfying cravings and regulating glycemic reactions.

Adoption of artificial sweeteners is accelerated by the fact that medical practitioners frequently suggest them as part of a diabetes treatment strategy. Furthermore, a growing number of consumers are actively searching for sugar-free and low-calorie alternatives in order to prevent or manage diabetes as awareness of the disease and its implications develops. The need for a wide variety of artificial sweeteners in food and beverage goods is being fueled by this trend, which is speeding up industry expansion.

Change in Consumer Preferences and Trends

Trends and consumer tastes are important drivers of growth in the artificial sweetener industry. In an effort to cut calories and control their weight, people are looking for sugar substitutes as knowledge of health and wellness issues grows. Artificial sweeteners play a major part in low-calorie, sugar-free products that are in high demand due to the shift towards healthy living.

As a result of the clean eating trend and the decline in processed sugars, artificial sweeteners are gaining popularity as better substitutes for a balanced diet. Furthermore, people are favoring items that contain artificial sweeteners due to the rising popularity of diet and exercise plans that emphasize consuming less sugar.

Furthermore, advances in artificial sweetener technologies and novel flavors have increased customer interest. The industry keeps growing as producers create new, more enticing sweeteners in response to these shifting tastes and preferences. The market for artificial sweeteners is growing rapidly due in part to customer demand for healthier, sugar-free alternatives.

North America Artificial Sweetener Market Overview

With the biggest market share, North America is predicted to keep expanding in the years to come. North America is the global leader in the artificial sweetener business due to its high rates of obesity and diabetes as well as its health-conscious consumer culture. The USDA (US Food and Drug Administration) reported that in 2023, artificial sweeteners were included in over 60% of packaged foods and beverages, an increase from 55% in the previous year. According to the CDC (Centers for Disease Control and Prevention), by 2024, 42% of American people actively look for low-calorie sweeteners in their diets. According to projections made by the Canadian Food Industry Association, the percentage of newly issued goods that contain artificial sweeteners would rise by 15% in 2023 compared to 2022. The American Diabetes Association is pushing for the substitution of artificial sweeteners, which will result in a 20% rise in the usage of these products by people with diabetes by 2024.

In addition, stringent laws governing the quantity of sugar allowed in food and beverages incentivize manufacturers to use artificial sweeteners, which furthers the domination of the area. Leading food and beverage firms in North America allocated 25% more to research and development for next-generation sweeteners in 2023. According to data from the US Department of Agriculture, stevia-based sweeteners have expanded at the highest rate and are expected to gain 30% of the market by 2024. With growing worries about obesity and associated health hazards, it is anticipated that North America's artificial sweetener industry will maintain its leadership position through innovation and adaptation to changing consumer tastes.

Artificial Sweetener Market Company Overview

Some of the industry leaders seen in the Global Artificial Sweetener Market Includes Tate & Lyle PLC, Cargill Incorporated, Archer Daniels Midland Company, DuPont de Nemours Inc., Ajinomoto Co. Inc., Ingredion Incorporated, GLG Life Tech Corporation.

Artificial Sweetener Market News

In January 2024, Ingredion Inc. unveiled PureCircle Clean Taste Solubility Solution, a plant-based clean label stevia option for producers. The secret is a natural sweetener that mimics the feeling of sugar without needing any extra ingredients to be added to the recipe. It can be used in a wide variety of recipes, including drinks, fruit preparations, syrups, liquid concentrates, bars, and sauces.
In June 2023, Prominent manufacturer of sugar substitutes Wisdom Natural Brands expanded its SweetLeaf product line to include three calorie-reduced sugars and two calorie-free sweeteners. Sugar is used for its taste, baking, browning, and caramelizing properties.
In July 2021, PepsiCo declared that by 2025, the company would cut the amount of sugar in their portfolios of sodas and iced tea beverages within the European Union (EU) by 25%. The company wants to attract the interest of health-conscious customers in the area by launching products with lower sugar content.

Product Type – Market breakup in 6 viewpoints:

1. Aspartame
2. Neotame
3. Sucralose
4. Acesulfame k
5. Saccharin
6. Others

Application – Market breakup in 5 viewpoints:

1. Bakery Products
2. Dairy Products
3. Confectionery
4. Beverages
5. Others

Country – Market breakup in 25 viewpoints:

North America

United States
Canada

Europe

France
Germany
Italy
Spain
United Kingdom
Belgium
the Netherlands
Turkey

Asia Pacific

China
Japan
India
Australia
South Korea
Thailand
Malaysia
Indonesia
New Zealand

Latin America

Brazil
Mexico
Argentina

Middle East & Africa

South Africa
Saudi Arabia
United Arab Emirates

All the Key players have been covered from 4 Viewpoints:

1. Overview
2. Recent Development
3. Product Portfolio
4. Financial Insights

Company Analysis:

1. Tate & Lyle PLC
2. Cargill Incorporated
3. Archer Daniels Midland Company
4. DuPont de Nemours Inc.
5. Ajinomoto Co. Inc.
6. Ingredion Incorporated
7. GLG Life Tech Corporation


1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Multiple Myeloma Market
6. Market Share Analysis
6.1 By Drugs Types
6.2 By Disease Types
6.3 By End User
6.4 By Country
7. Drugs Types
7.1 Chemotherapy
7.2 Protease Inhibitors
7.3 Monoclonal Antibody
7.4 Others
8. Disease Types
8.1 Active multiple myeloma
8.2 Smoldering multiple myeloma
9. End User
9.1 Hospitals
9.2 Clinics
9.3 Others
10. Countries
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Thailand
10.3.7 Malaysia
10.3.8 Indonesia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 United Arab Emirates
11. Porter's Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threats
13. Key Players Analysis
13.1 Novartis AG
13.1.1 Overviews
13.1.2 Recent Developments
13.1.3 Products Portfolio
13.1.4 Revenues
13.2 Abbvie Inc
13.2.1 Overviews
13.2.2 Recent Developments
13.2.3 Products Portfolio
13.2.4 Revenues
13.3 Sanofi
13.3.1 Overviews
13.3.2 Recent Developments
13.3.3 Products Portfolio
13.3.4 Revenues
13.4 Johnson and Johnson
13.4.1 Overviews
13.4.2 Recent Developments
13.4.3 Products Portfolio
13.4.4 Revenues
13.5 Baxter International Inc.
13.5.1 Overviews
13.5.2 Recent Developments
13.5.3 Products Portfolio
13.5.4 Revenues
13.6 Pfizer Inc.
13.6.1 Overviews
13.6.2 Recent Developments
13.6.3 Products Portfolio
13.6.4 Revenues
13.7 Takeda Pharmaceutical Company Ltd
13.7.1 Overviews
13.7.2 Recent Developments
13.7.3 Products Portfolio
13.7.4 Revenues
13.8 Bristol-Myers Squibb Company
13.8.1 Overviews
13.8.2 Recent Developments
13.8.3 Products Portfolio
13.8.4 Revenues

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings